Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Current Liabilities (2016 - 2026)

Collegium Pharmaceutical has reported Total Current Liabilities over the past 11 years, most recently at $440.0 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 13.64% year-over-year to $440.0 million; the TTM value through Dec 2025 reached $440.0 million, down 13.64%, while the annual FY2025 figure was $440.0 million, 13.64% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $440.0 million at Collegium Pharmaceutical, down from $452.9 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $509.5 million in Q4 2024 and troughed at $226.8 million in Q2 2021.
  • A 5-year average of $406.7 million and a median of $437.5 million in 2023 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: surged 82.99% in 2022 and later fell 13.64% in 2025.
  • Year by year, Total Current Liabilities stood at $279.6 million in 2021, then skyrocketed by 55.14% to $433.7 million in 2022, then rose by 5.58% to $457.9 million in 2023, then increased by 11.27% to $509.5 million in 2024, then fell by 13.64% to $440.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for COLL at $440.0 million in Q4 2025, $452.9 million in Q3 2025, and $464.6 million in Q2 2025.